Zobrazeno 1 - 10
of 1 020
pro vyhledávání: '"Roger S, Blumenthal"'
Autor:
Yehuda Eidensohn, Anjali Bhatla, Jie Ding, Roger S. Blumenthal, Seth S. Martin, Francoise A. Marvel
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100686- (2024)
Objective: Elevated lipoprotein(a) [Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD). We evaluated the frequency of testing for elevated Lp(a) and subsequent management at the Johns Hopki
Externí odkaz:
https://doaj.org/article/72dbf2ae5aa74f0289174508ad966fc1
Publikováno v:
American Heart Journal Plus, Vol 45, Iss , Pp 100443- (2024)
Climate change is a public health crisis predominantly due to fossil fuel combustion, that challenges planetary and human health. Considerable evidence exists to demonstrate the impact climate change has on cardiovascular disease primarily through ai
Externí odkaz:
https://doaj.org/article/58d2efbc49ed4ca3bdb3044a6452ed6c
Autor:
Deen L. Garba, Alexander C. Razavi, Roger S. Blumenthal, Neil J. Stone, Tamar Polonsky, Sadiya S. Khan, Lili A. Barouch
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100705- (2024)
Externí odkaz:
https://doaj.org/article/e32bb10e92104760829ca85f4fe312ee
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101113- (2024)
Externí odkaz:
https://doaj.org/article/d9d2c597ada6462fb0de152be57e716f
Autor:
Deen L. Garba, Alan P. Jacobsen, Roger S. Blumenthal, Matthew W. Martinez, Chiadi E. Ndumele, Alexis M. Coslick, Lili A. Barouch
Publikováno v:
American Heart Journal Plus, Vol 44, Iss , Pp 100413- (2024)
The American Heart Association (AHA) has devised Life's Essential 8, a set of eight evidence-based health behaviors that play a crucial role in optimizing cardiovascular health and overall well-being. In addition to Life's Essential 8, enhanced scree
Externí odkaz:
https://doaj.org/article/10ecf78bab2b46cda348c4ac9b23564d
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Following the publication of results from multiple landmark cardiovascular outcome trials of antihyperglycemic medications over the past 8 years, there has been a major shift in the focus of care for people with type 2 diabetes, from control of hyper
Externí odkaz:
https://doaj.org/article/22abf90759d445cbb4df8b8027504c99
Autor:
Alexander C. Razavi, LaTonia C. Richardson, Fátima Coronado, Omar Dzaye, Harpreet S. Bhatia, Anurag Mehta, Arshed A. Quyyumi, Viola Vaccarino, Matthew J. Budoff, Khurram Nasir, Sotirios Tsimikas, Seamus P. Whelton, Michael J. Blaha, Roger S. Blumenthal, Laurence S. Sperling
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100674- (2024)
Objective: Lipoprotein(a) [Lp(a)] is an atherogenic and prothrombotic lipoprotein associated with atherosclerotic cardiovascular disease (ASCVD). We assessed the association between regular aspirin use and ASCVD mortality among individuals with versu
Externí odkaz:
https://doaj.org/article/397d51a3f8954de6bb2d5475f7fe1bf8
Autor:
Carlos Iribarren, Meng Lu, Roberto Elosua, Martha Gulati, Nathan D. Wong, Roger S. Blumenthal, Steven Nissen, Jamal S. Rana
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100661- (2024)
Objective: Many studies support the notion that polygenic risk scores (PRS) improve risk prediction for coronary heart disease (CHD) beyond conventional risk factors. However, PRS are not yet considered risk-enhancing factor in guidelines. Our object
Externí odkaz:
https://doaj.org/article/4d6efadf5cc94724a96e6b32a43ce67f
Autor:
Omar Chehab, Elie Akl, Ashkan Abdollahi, Ralph Zeitoun, Bharath Ambale-Venkatesh, Colin Wu, Russell Tracy, Roger S. Blumenthal, Wendy S. Post, Joao A. C. Lima, Annabelle Rodriguez
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Emerging research indicates that high HDL-C levels might not be cardioprotective, potentially worsening cardiovascular disease (CVD) outcomes. Yet, there is no data on HDL-C's association with other CVD risk factors like myocardial fibrosis,
Externí odkaz:
https://doaj.org/article/82f0c66298e64295964f0933ffdf170d
Autor:
Justin B. Echouffo‐Tcheugui, Sui Zhang, Roberta Florido, James S. Pankow, Erin D. Michos, Ronald B. Goldberg, Vijay Nambi, Gary Gerstenblith, Wendy S. Post, Roger S. Blumenthal, Christie M. Ballantyne, Josef Coresh, Elizabeth Selvin, Chiadi E. Ndumele
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background It is unclear how metabolic syndrome (MetS) and diabetes affect Gal‐3 (galectin 3) levels and the resulting implications for heart failure (HF) risk. We assessed relationships of MetS and diabetes with Gal‐3, and their joint associatio
Externí odkaz:
https://doaj.org/article/2ae882273ed64fc8ac591dde05d50866